obicetrapib
obicetrapib: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| NEWAMSTERDAM PHARMA CO N.V. (NAMS) | Phase 1 |
Clinical Trials (1)
A Randomized, Double-Blind, Placebo-Controlled Parallel Trial to Assess the Effects of Obicetrapib on Levels of Antioxidants in Plasma and HDL Particles in Healthy Volunteers: The VERMEER Study
Frequently asked questions
Who is developing obicetrapib?
obicetrapib is being developed by NEWAMSTERDAM PHARMA CO N.V..
How many clinical trials involve obicetrapib?
BioSniper tracks 1 clinical trial involving obicetrapib.
Get deeper analysis on obicetrapib
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis